ArticleCureus2026
Active Surveillance of Iodinated Contrast Media-Induced Reactions and Associated Risk Factors Among Patients Undergoing Radiologic Procedures in Tertiary Hospitals in Tanzania: A Prospective Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundExposure to iodinated contrast media (ICM), particularly at higher doses, carries significant risks of acute hypersensitivity and organ toxicity, especially involving the kidneys and cardiovascular system. Documenting these reactions is vital for patient safety, risk management, and medico-legal considerations. This study aimed to determine the incidence of ICM-induced adverse reactions and to identify associated risk factors among patients undergoing radiologic imaging in tertiary hospitals in Tanzania. MATERIALS AND
methodsThis prospective cohort study enrolled 283 patients undergoing contrast-based radiologic procedures between March and May 2024 at two tertiary hospitals in the Ilala district, Tanzania. Data on demographics, drug history, comorbidities, and prior contrast exposure were collected through structured questionnaires and patient files. Blood pressure and BMI were measured, with hypertension defined as BP ≥140/90 mmHg or a history of treatment. Reactions were assessed at baseline and post-procedure at 24, 72, and 168 hours. Data analysis was performed using SPSS version 27 (IBM Corp. Released 2020. IBM SPSS Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp.), applying univariate and multivariate analysis, with p-values <0.05 considered statistically significant.
resultsThe incidence of any ICM-induced reaction was 39.2% (111/283). Acute reactions predominated, including gastrointestinal (27.9%), neurological (18.0%), and dermatological (13.5%) symptoms, while delayed events were mainly contrast-associated acute kidney injury (6.3%) and delayed cutaneous reactions (4/111, 3.6%). Significant risk factors included normal BMI (adjusted risk ratio (ARR) = 1.445), overweight (ARR = 1.305), neurological conditions (ARR = 1.496), cardiopulmonary disease (ARR = 1.335), oncologic indications (ARR = 1.350), anemia (ARR = 1.490), and stage 2 renal failure (ARR = 2.143). Interestingly, diabetes mellitus was associated with a lower risk (ARR = 0.540).
conclusionsThese findings highlight that acute reactions are more common than delayed ones, emphasizing the need for careful risk assessment and targeted preventive strategies during contrast procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.